AIM
CRL icon

Achmea Investment Management’s Charles River Laboratories CRL Stock Holding History

Achmea Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,186
Closed -$896K – 652
2022
Q2 		$896K Hold
4,186
– – 0.03% 421
2022
Q1 		$1.19M Sell
4,186
-226
-5% -$69.7K 0.03% 420
2021
Q4 		$1.66M Hold
4,412
– – 0.08% 212
2021
Q3 		$1.82M Buy
4,412
+372
+9% +$154K 0.06% 354
2021
Q2 		$1.49M Buy
+4,040
New +$1.35M 0.05% 375

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Achmea Investment Management's CRL Position: Q3 2022 in Review

Achmea Investment Management sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 4,186 shares — an estimated $896K sold.

Achmea Investment Management first reported a position in CRL in Q2 2021 and held it in 5 quarters. The position peaked at $1.82M in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Achmea Investment Management reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Achmea Investment Management sold 4,186 Charles River Laboratories shares in Q3 2022, an estimated $896K.
  • Achmea Investment Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 5 quarters.
  • Achmea Investment Management's Charles River Laboratories position peaked at $1.82M in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Achmea Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.